93 related articles for article (PubMed ID: 9793362)
1. [Candida albicans morphotypes and in vitro adhesivity to cells of the human oral mucosa in HIV-positive and AIDS patients after exposure of blastospores to fluconazole. II].
Spadari E; Arosio M; Malighetti V; Bellotti MG; Artini MZ; Spadari F; Riviera L
Minerva Stomatol; 1998; 47(7-8):293-7. PubMed ID: 9793362
[TBL] [Abstract][Full Text] [Related]
2. [Candida albicans: the relationship between morphotypes and in-vitro adhesivity to the oral mucosa cells of HIV-positive and AIDS patients. I].
Malighetti V; Arosio M; Bellotti MG; Spadari E; Zambellini Artini M; Spadari F; Riviera L
Minerva Stomatol; 1998 Sep; 47(9):351-9. PubMed ID: 9835741
[TBL] [Abstract][Full Text] [Related]
3. [Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV].
Drobacheff C; Manteaux A; Millon L; Reboux G; Barale T; Laurent R
Ann Dermatol Venereol; 1996; 123(2):85-9. PubMed ID: 8761757
[TBL] [Abstract][Full Text] [Related]
4. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
[TBL] [Abstract][Full Text] [Related]
5. [Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS].
Diz P; Ocampo A; Miralles C; Otero I; Iglesias I; Martínez C
Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):36-9. PubMed ID: 8461371
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of adhesive properties of Candida albicans isolated from the oral cavity in HIV positive patients.
Macura AB; Bort A
Wiad Parazytol; 2001; 47(4):723-8. PubMed ID: 16886417
[TBL] [Abstract][Full Text] [Related]
7. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus.
Willis AM; Coulter WA; Fulton CR; Hayes JR; Bell PM; Lamey PJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):317-21. PubMed ID: 11250629
[TBL] [Abstract][Full Text] [Related]
8. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients.
Jandourek A; Vaishampayan JK; Vazquez JA
AIDS; 1998 Jun; 12(9):1033-7. PubMed ID: 9662200
[TBL] [Abstract][Full Text] [Related]
10. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
Goldman M; Cloud GA; Wade KD; Reboli AC; Fichtenbaum CJ; Hafner R; Sobel JD; Powderly WG; Patterson TF; Wheat LJ; Stein DK; Dismukes WE; Filler SG; ;
Clin Infect Dis; 2005 Nov; 41(10):1473-80. PubMed ID: 16231260
[TBL] [Abstract][Full Text] [Related]
11. Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients.
Brown DM; Jabra-Rizk MA; Falkler WA; Baqui AA; Meiller TF
Pediatr Dent; 2000; 22(3):234-8. PubMed ID: 10846737
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Candida albicans isolates from the oral cavity of HIV-positive patients.
Woldeamanuel Y; Abate D
Ethiop Med J; 1998 Oct; 36(4):235-43. PubMed ID: 11957299
[TBL] [Abstract][Full Text] [Related]
13. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
[TBL] [Abstract][Full Text] [Related]
14. [Susceptibility to fluconazole and itraconazole in isolates of Candida spp. from HIV-positive and HIV-negative patients].
Bernal S; Gutiérrez MJ; Serrano MC; Chávez M; Valverde A; Quindós G; Mazuelos EM
Rev Esp Quimioter; 2000 Mar; 13(1):60-3. PubMed ID: 10855026
[TBL] [Abstract][Full Text] [Related]
15. [In vitro study of oral Candida albicans in virulence from HIV-positive individuals].
Liu XS; Liu HW; Guo ZJ; Luan WM
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 May; 40(3):211-4. PubMed ID: 15938881
[TBL] [Abstract][Full Text] [Related]
16. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD
Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582
[TBL] [Abstract][Full Text] [Related]
17. Oral colonization by Candida spp. among AIDS household contacts.
Milan EP; Kallás EG; Costa PR; da Matta DA; Lopes Colombo A
Mycoses; 2001; 44(7-8):273-7. PubMed ID: 11714061
[TBL] [Abstract][Full Text] [Related]
18. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
Maninder J; Usha A
J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
[TBL] [Abstract][Full Text] [Related]
19. [Oesophageal candidiasis: clinical and mycological analysis].
Olmos MA; Araya V; Concetti H; Ramallo J; Piskorz E; Pérez H; Cahn P; Kaufman S; Guelfand L
Acta Gastroenterol Latinoam; 2005; 35(4):211-8. PubMed ID: 16496852
[TBL] [Abstract][Full Text] [Related]
20. Oral candidosis and associated Candida species in HIV-infected Cambodians exposed to antimycotics.
Schmidt-Westhausen AM; Bendick C; Reichart PA; Samaranayake LP
Mycoses; 2004 Oct; 47(9-10):435-41. PubMed ID: 15504130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
